Tremelimumab: 237 Clinical Trials, Page 10 of 24

Hide Studies Not Open or Pending

97

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

Condition(s):Advanced Cervical Adenocarcinoma; Advanced Vaginal Carcinoma; Advanced Vulvar Carcinoma; Human Papillomavirus-Related Cervical Squamous Cell Carcinoma; Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma; Metastatic Cervical Adenocarcinoma; Metastatic Cervical Carcinoma; Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Metastatic Vaginal Adenocarcinoma; Metastatic Vaginal Carcinoma; Metastatic Vulvar Carcinoma; Recurrent Cervical Adenocarcinoma; Recurrent Cervical Carcinoma; Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Recurrent Vaginal Carcinoma; Recurrent Vulvar Carcinoma; Stage III Cervical Cancer AJCC v8; Stage III Vaginal Cancer AJCC v8; Stage III Vulvar Cancer AJCC v8; Stage IIIA Cervical Cancer AJCC v8; Stage IIIA Vulvar Cancer AJCC v8; Stage IIIB Cervical Cancer AJCC v8; Stage IIIB Vulvar Cancer AJCC v8; Stage IIIC Vulvar Cancer AJCC v8; Stage IV Cervical Cancer AJCC v8; Stage IV Vaginal Cancer AJCC v8; Stage IV Vulvar Cancer AJCC v8; Stage IVA Cervical Cancer AJCC v8; Stage IVA Vaginal Cancer AJCC v8; Stage IVA Vulvar Cancer AJCC v8; Stage IVB Cervical Cancer AJCC v8; Stage IVB Vaginal Cancer AJCC v8; Stage IVB Vulvar Cancer AJCC v8; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Adenocarcinoma; Vulvar Squamous Cell CarcinomaLast Updated:September 13, 2023Completed

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.